TrialArthritis research & therapy2021

Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT.

Jürgen Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.